- $114.86m
- $125.34m
- CNY179.05m
- 19
- 59
- 64
- 45
Annual income statement for The9, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.342 | 0.625 | 136 | 108 | 179 |
Cost of Revenue | |||||
Gross Profit | -1 | -0.189 | 47.8 | -47.3 | -32.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 173 | -409 | 419 | 821 | 494 |
Operating Profit | -172 | 410 | -283 | -712 | -315 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -193 | 403 | -391 | -693 | -144 |
Provision for Income Taxes | |||||
Net Income After Taxes | -193 | 396 | -391 | -693 | -144 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -191 | 397 | -411 | -975 | 20 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -191 | 397 | -411 | -975 | 20 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -14 | 3.52 | -0.705 | -0.526 | 0.021 |